EDESA BIOTECH, INC. (EDSA) Return on equity 2016–2021
EDESA BIOTECH, INC. (EDSA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-102.2%FY2021 · since FY2016: -40.8% → -102.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -102.2% | -6.2 pp |
| FY2020 | -96.0% | — |
| FY2018 | -47.8% | +20.2 pp |
| FY2017 | -68.0% | -27.2 pp |
| FY2016 | -40.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More EDSA financial trends
EDSA RevenueEDSA Net incomeEDSA Net marginEDSA Gross profitEDSA Gross marginEDSA Operating incomeEDSA Operating marginEDSA Operating cash flowEDSA Free cash flowEDSA Capital expendituresEDSA Stock buybacksEDSA Dividends paidEDSA Total assetsEDSA Total liabilitiesEDSA Shareholders’ equityEDSA overview →